Chronic fatigue syndrome against the background of the COVID-19 pandemic

Nikitina A.J.; Levin O.S.

doi:https://doi.org/10.17116/jnevro202112110292

Close metadata

Recommended articles:

Laboratory tests for diagnostics of cell immunity against SARS-CoV-2 (review of literature). Laboratory Service. 2024;(3):31-36

Localization features of FAP-positive activated stromal cells in fibrosis in patients with new coronavirus infection COVID-19. Russian Journal of Archive of Pathology. 2024;(6):5-14

The role of drug Cytoflavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146

Laparoscopic appendectomy for appendiceal mucocele in a patient with COVID-19. Endoscopic Surgery. 2024;(6):41-45

Long-term outcomes in patients after hospital treatment for COVID-19 (three-year follow-up data). Russian Journal of Preventive Medicine. 2024;(12):114-121

Selective anosmia for monomolecular odorants in a cohort of young individuals. Russian Rhinology. 2024;(4):262-268

The results of the examination of patients with chronic generalized periodontitis after novel coronavirus infection. Russian Journal of Stomatology. 2024;(4):18-22

Waiting for Disease X: a plan for preparing Russian laboratory services for the next pandemic. Laboratory Service. 2024;(4):5-11

Development and testing of the first domestic automatic cartridge-type POCT platform for the qualitative determination of SARS-CoV-2 RNA. Laboratory Service. 2024;(4):21-27

Diffuse changes in the brain in the acute phase of COVID-19 and after infection. Russian Journal of Archive of Pathology. 2025;(1):5-15

Abstract:

The more we learn about the new coronavirus infection, the more we understand that we will feel the echoes of the pandemic for many years, and those who have successfully endured the acute phase of COVID-19 may face the consequences of the infection. One of the most frequent manifestations will be the development of chronic fatigue syndrome (CFS) after COVID-19. This article discusses the possible causes of the development of CFS, as well as possible ways of its treatment and prevention.

Keywords:

COVID-19

coronavirus

SARS-CoV2

tofizopam

grandaxin

chronic fatigue syndrome

Authors:

Nikitina A.J.

Russian Medical Academy of continuous Professional Education

Levin O.S.

Russian Medical Academy of Continuous Professional Education

SPIN RSCI: 5342-1373
Scopus AuthorID: 57147160800
ORCID: 0000-0003-3872-5923

Received:

12.10.2021

Accepted:

18.10.2021

Close metadata

References:

Kassem S, Watad A, Bragazzi NL, Lichtbroun M, Martini M, Perricone C, Amital H, Shoenfeld Y. On chronic fatigue syndrome and nosological categories. Clinical Rheumatology. 2018;37(5):1161-1170. https://doi.org/10.1007/s10067-018-4009-2
Rivera MC, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, Lidbury BA. Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review. Diagnostics. 2019;9(3):91. https://doi.org/10.3390/diagnostics9030091
Sunnquist LAJM, Nehrke P, Goudsmit EM. A comparison of case definitions for myalgic encephalomyelitis and chronic fatigue syndrome. Journal of Chronic Diseases and Management. 2017;2(2):45-51.
Maclachlan L, Watson S, Gallagher P, Finkelmeyer A, Jason LA, Sunnquist M, Newton JL. Are current chronic fatigue syndrome criteria diagnosing different disease phenotypes? PloS One. 2017;12(10):e0186885. https://doi.org/10.1371/journal.pone.0186885
Twisk FNM. Myalgic Encephalomyelitis, chronic fatigue syndrome, and Systemic Exertion Intolerance Disease: Three distinct clinical entities. Challenges 9. 2018;1:19. https://doi.org/10.3390/challe9010019
Twisk FNM. Myalgic encephalomyelitis, chronic fatigue syndrome, and chronic fatigue: three distinct entities requiring complete different approaches. Current Rheumatology Reports. 2019;21(6):27. https://doi.org/10.1007/s11926-019-0823-z
Komaroff AL. Advances in understanding the pathophysiology of chronic fatigue syndrome. Jama. 2019;322(6):499-500. https://doi.org/10.1001/jama.2019.8312
Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, Baxter A, Nathan N, Anderson W, Gordon E. Metabolic features of chronic fatigue syndrome. Proceedings of the National Academy of Sciences. 2016;113(37):5472-5480. https://doi.org/10.1073/pnas.1607571113
Lim E-J, Ahn Y-C, Jang E-C, Lee S-W, Lee S-H, Son C-G. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Journal of Translational Medicine. 2020;18(1):1-15. https://doi.org/10.1186/s12967-020-02269-0
Morris G, Maes M, Berk M, Puri BK. Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop? Metabolic Brain Disease. 2019;34(2):385-415. https://doi.org/10.1007/s11011-019-0388-6
Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L, Magnus P. Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008—2012. BMC Medicine. 2014;12(1):1-7. https://doi.org/10.1186/s12916-014-0167-5
Pietrangelo T, Fulle S, Coscia F, Gigliotti PV, Fanò-Illic G. Old muscle in young body: an aphorism describing the Chronic Fatigue Syndrome. European Journal of Translational Mycology. 2018;28(3):32-37. https://doi.org/10.4081/ejtm.2018.7688
Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Frontiers in Pediatrics. 2019;7:12. https://doi.org/10.3389/fped.2019.00012
Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, Scheibenbogen C, Murovska M, Prusty BK. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Journal of Translational Medicine. 2018;16(1):1-25. https://doi.org/10.1186/s12967-018-1644-y
Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue: Biomedicine, Health & Behavior. 2020;8(2):61-69. https://doi.org/10.1080/21641846.2020.1778227
Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurology. 2011;11(1):1-7. https://doi.org/10.1186/1471-2377-11-37
Lee SH, Shin H-S, Park HY, Kim JL, Lee JJ, Lee H, Won S-D, Han W. Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle east respiratory syndrome survivors. Psychiatry Investigation. 2019;16(1):59. https://doi.org/10.30773/pi.2018.10.22.3
Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Medical Hypotheses. 2021;146:110469. https://doi.org/10.1016/j.mehy.2020.110469
Bosso M, Thanaraj TA, Abu-Farha M, Alanbaei M, Abubaker J, Al-Mulla F. The Two Faces of ACE2: the Role of ACE2 Receptor and its Polymorphisms in Hypertension and COVID-19. Molecular Therapy-Methods & Clinical Development. 2020. https://doi.org/10.1016/j.omtm.2020.06.017
Varga Z, Flammer AF, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial Cell Infection and Endotheliitis in COVID-19. The Lancet. 2020;395(10234):1417-1418. https://doi.org/10.1016/S0140-6736(20)30937-5
Achar A, Ghosh C. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance. Cells. 2020;9(11):2360. https://doi.org/10.3390/cells9112360
Montalvan V, Lee J, Bueso T, Toledo JD, Rivas K. Neurological Manifestations of COVID-19 and Other Coronavirus Infections: a Systematic Review. Clinical Neurology and Neurosurgery. 2020;194:105921. https://doi.org/10.1016/j.clineuro.2020.105921
de Oliveira RMF, de Souza Aguiar PHC, de Paula RWRM, Simões CEN, Almeida LG, Barceló A, de Siqueira Galil AG. Stroke in Patients Infected by the Novel Coronavirus and its Causal Mechanisms: A Narrative Review. Journal of the American College of Emergency Physicians Open. 2020;45:45-51. https://doi.org/10.1002/emp2.12332
Ritchie K, Chan D. The Emergence of Cognitive COVID. World Psychiatry. 2021;20(1):52-53. https://doi.org/10.1002/wps.20837
Alexopoulos H, Magira E, Bitzogli K, Kafasi N, Vlachoyiannopoulos P, Tzioufas A, Kotanidou A, Dalakas. Anti—SARS-CoV-2 Antibodies in the CSF, Blood-brain barrier Dysfunction, and Neurological Outcome Studies in 8 Stuporous and Komatose patients. Neurol Neuroimmunol Neuroinflamm. 2020;7:e893. https://doi.org/10.1212/NXI.0000000000000893
Rege S. COVID-19 and the Brain — Pathogenesis and Neuropsychiatric Manifestations of SARS-CoV-2 CNS Involvement MRCPsych, FRANZCP. 2020;12:23-29.
Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain, behavior, and immunity. 2010;24(7):1209-1217. https://doi.org/10.1016/j.bbi.2010.04.012
Glassford JAG. The neuroinflammatory etiopathology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Frontiers in physiology. 2017;8:88. https://doi.org/10.3389/fphys.2017.00088
Hatziagelaki E, Adamaki M, Tsilioni I, Dimitriadis G, Theoharides CT. Myalgic encephalomyelitis/chronic fatigue syndrome—metabolic disease or disturbed homeostasis due to focal inflammation in the hypothalamus? Journal of Pharmacology and Experimental Therapeutics. 2018;367(1):155-167. https://doi.org/10.1124/jpet.118.250845
Gerwyn M, Maes M. Mechanisms explaining muscle fatigue and muscle pain in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A review of recent findings. Current rheumatology reports. 2017;19(1):1. https://doi.org/10.1007/s11926-017-0628-x
Neefjes ECW, Hurk RMVD, Blauwhoff‐Buskermolen S, MJDL van der Vorst, Becker‐Commissaris A, de van der Schueren MAE, Buffart LM, Verheul HMV. Muscle mass as a target to reduce fatigue in patients with advanced cancer. Journal of cachexia, sarcopenia and muscle. 2017;8(4):623-629. https://doi.org/10.1002/jcsm.12199
Berger JR. COVID-19 and the Nervous System. Journal of neurovirology. 2020;26:143-148. https://doi.org/10.1007/s13365-020-00840-5
Weng L-M, Su X, Wang X-Q. Pain Symptoms in Patients with Coronavirus Disease (COVID-19): A Literature Review. Journal of Pain Research. 2021;14:147-159. https://doi.org/10.2147/JPR.S269206
Oka T, Tanahashi T, Sudo N, Lkhagvasuren B, Yamada Y. Changes in fatigue, autonomic functions, and blood biomarkers due to sitting isometric yoga in patients with chronic fatigue syndrome. BioPsychoSocial medicine. 2018;12(1):1-11. https://doi.org/10.1186/s13030-018-0123-2
Robinson LJ, Gallagher P, Watson S, Pearce R, Finkelmeyer A, Maclachlan L, Newton JL. Impairments in cognitive performance in chronic fatigue syndrome are common, not related to co-morbid depression but do associate with autonomic dysfunction. PloS One. 2019;14(2):e0210394. https://doi.org/10.1371/journal.pone.0210394
Rasouli O, Gotaas ME, Stensdotter A-K, Skovlund E, Landrø NL, Dåstøl P, Fors EA. Neuropsychological dysfunction in chronic fatigue syndrome and the relation between objective and subjective findings. Neuropsychology. 2019;33(5):658. https://doi.org/10.1037/neu0000550
Mueller C, Lin JC, Sheriff S, Maudsley AA, Younger JW. Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain imaging and behavior. 2020;14(2):562-572. https://doi.org/10.1007/s11682-018-0029-4
Wright A, Fisher PL, Baker N, O’Rourke L, Gemma M. Cherry Perfectionism, depression and anxiety in chronic fatigue syndrome: A systematic review. Journal of psychosomatic research. 2020;110322. https://doi.org/10.1016/j.jpsychores.2020.110322
Larkin D, Martin CR. The interface between chronic fatigue syndrome and depression: A psychobiological and neurophysiological conundrum. Neurophysiologie Clinique/Clinical Neurophysiology. 2017;47(2):123-129.
Daniels J, Brigden A, Kacorova A. Anxiety and depression in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): examining the incidence of health anxiety in CFS/ME. Psychology and Psychotherapy: Theory, Research and Practice. 2017;90(3):502-509. https://doi.org/10.1016/j.ijchp.2019.11.003
McManus S, Bebbington PE, Jenkins R, Brugha T. Mental health and wellbeing in england: The adult psychiatric morbidity survey 2014. NHS digital. 2016;8:56-59.
Deary V, Chalder T. Personality and perfectionism in chronic fatigue syndrome: a closer look. Psychology and Health. 2010;25(4):465-475. https://doi.org/10.1080/08870440802403863
Luyten P, Houdenhove BV, Cosyns N, Broeck ALV. Are patients with chronic fatigue syndrome perfectionistic — or were they? A case-control study. Personality and Individual Differences. 2006;40(7):1473-1483. https://doi.org/10.1016/j.paid.2005.10.023
Brooks SK, Chalder T, Rimes KA. Chronic fatigue syndrome: cognitive, behavioural and emotional processing vulnerability factors. Behavioural and cognitive psychotherapy. 2017;45(2):156-169. https://doi.org/10.1017/S1352465816000631
Wilshire CE, Kindlon T, Courtney R, Matthees A, Tuller D, Geraghty K, Levin B. Rethinking the treatment of chronic fatigue syndrome — a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT. BMC psychology. 2018;6(1):1-12. https://doi.org/10.1186/s40359-018-0218-3
Castro-Marrero J, Sáez‐Francàs N, Santillo D, Alegre J. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome. British journal of pharmacology. 2017;174(5):345-369. https://doi.org/10.1111/bph.13702
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract. 2012;16(2):77-84. https://doi.org/10.3109/13651501.2012.667114
Aleksandrova EA, Parshina EV, Borodacheva IV, Suslov AG, Belyakov KM, Yulin VS, Fomin SV. The possibilities of daytime anxiolytics in the correction of residual neurological manifestations of COVID-19. 2021. (In Russ.). https://doi.org/10.21518/2079-701X-2021-12-50-60